Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

NCT00013520 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1125

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Abacavir sulfate, Lamivudine and Zidovudine
DRUG: Atazanavir
DRUG: Lamivudine/Zidovudine
DRUG: Abacavir sulfate
DRUG: Efavirenz
DRUG: Nevirapine
DRUG: Lamivudine
DRUG: Stavudine
DRUG: Zidovudine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)